Sage Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2020
Period Ending	Aug '25 Aug 4, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2016 - 2020
Market Capitalization	450	184	79	37	129	135	Upgrade
Market Cap Growth	264.37%	134.16%	111.59%	-71.15%	-4.45%	141.46%	Upgrade
Enterprise Value	400	171	73	33	106	127	Upgrade
Last Close Price	1.11	0.44	0.30	0.14	0.51	0.72	Upgrade
PB Ratio	3.64	1.47	1.07	0.45	1.46	2.05	Upgrade
P/TBV Ratio	3.64	1.47	1.07	0.45	1.46	2.05	Upgrade
P/FCF Ratio	-	-	1784.50	-	-	-	Upgrade
P/OCF Ratio	52.43	-	39.42	-	-	-	Upgrade
EV/FCF Ratio	-56.68	-	1667.76	-	-	-	Upgrade
Debt / Equity Ratio	0.00	0.00	0.01	0.01	0.01	0.01	Upgrade
Debt / FCF Ratio	-	-	10.57	-	-	-	Upgrade
Quick Ratio	3.33	4.67	7.26	2.98	5.90	1.44	Upgrade
Current Ratio	3.35	4.70	7.71	3.22	6.30	1.52	Upgrade
Return on Equity (ROE)	-0.43%	-0.02%	-15.94%	-2.71%	-13.66%	-13.09%	Upgrade
Return on Assets (ROA)	-4.35%	-4.99%	-6.12%	-9.37%	-8.63%	-6.52%	Upgrade
Return on Capital (ROIC)	-6.98%	-7.07%	-8.76%	-11.52%	-9.34%	-6.94%	Upgrade
Earnings Yield	-0.09%	-0.01%	-15.74%	-6.21%	-8.18%	-6.64%	Upgrade
FCF Yield	-1.57%	-8.97%	0.06%	-95.58%	-11.82%	-9.81%	Upgrade
Buyback Yield / Dilution	-39.68%	-23.80%	-0.64%	-16.62%	-18.83%	-32.66%	Upgrade

Updated Nov 15, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.